Introduction
============

Epilepsy is one of the most common neurological disorders, affecting almost 0.5%--1.0% of the general population ([@b24]). Patients usually respond well to pharmacological treatment. However, approximately, 25%--30% of patients are drug-resistant ([@b11]). For this group, surgery can be a suitable therapeutic option ([@b10], [@b12]; [@b27]). Surgical treatment requires an exhaustive presurgical evaluation in order to identify the epileptogenic area and minimize the side effects of the operation. Presurgical evaluation usually includes, among others ([@b20]; [@b22]), electroencephalography (EEG), video-electroencephalography (v-EEG), magnetic resonance imaging (MRI) and single photon emission computerized tomography (SPECT).

Interictal or basal SPECT is a presurgical study not performed systematically in the majority of epilepsy-surgery units because it is affected by a number of drawbacks that limits its results ([@b13]). In order to overcome these problems, some epilepsy-surgery units perform ictal SPECT, in which a radiotracer is intravenously administered after a seizure onset is identified ([@b23]; [@b25]; [@b13]; [@b5]). Ictal SPECT has been shown to be an accurate means of localization of temporal lobe seizures when the tracer is injected immediately after the seizure ([@b6]; [@b26]). The localizing information was better when the injection was given soon after seizure onset ([@b18]; [@b2]; [@b25]).

Sometimes, during v-EEG recording and in order to increase the probability of seizures, pharmacologically induced stimulation has been performed using different drugs; ie, clonidine, metohexital, etc ([@b15]; [@b4]; [@b21]). Among these, the use of etomidate, a nonbarbiturate hypnotic, short-lived imidazol derivate, has been rare ([@b9]; [@b17]).

In the Hospital La Princesa, currently, we are characterizing the response to etomidate in patients with mesial temporal lobe epilepsy (MTLE) and undergoing evaluation for surgery while they are monitored with v-EEG using foramen ovale electrodes (FOE). It is not our objective to describe this method in detail (see Dominguez-Gadea et al 2006), but to show a fortunate result obtained in the context of that study, describing the case of a patient that suffered a seizure during etomidate infusion after the radiotracer injection for activated SPECT. This allowed us to obtain that which is, to our knowledge, the first true initial ictal SPECT (recorded during the true beginning of the seizure and not during the propagated ictal activity) described in the literature. We have implemented a numerical model previously published ([@b1]) for the analysis and discussion.

Case report
===========

A 14-year-old, right handed girl with a diagnosis of refractory temporal lobe epilepsy (TLE) was referred to the Epilepsy Unit, Hospital Universitario "La Princesa", Madrid, Spain for evaluation and surgical treatment of epilepsy.

Pregnancy and birth were normal. No familial epilepsy history was reported. Seizures began at age 2 years, after a viral vaccination. Nowadays, she complains of daily seizures.

Previously tried anti-epileptic drugs (AED) included phenitoin, carbamacepine, etosuximide, zonisapride, and levetiracetam. At the present time pharmacological treatment included (mg/d): topiramate 300; oxcarbamazepine 1500; valproate 600; and clobazam 10.

Methods
=======

Presurgical evaluation, following the previously described La Princesa Hospital protocol ([@b20]; [@b22]), included neurological and neuropsychological examinations, scalp EEG (Nihon Kohden^®^) with 19 electrodes according the 10--20 international system, 1.5 T magnetic resonance imaging (MRI; General Electric^®^) and interictal single photon emission computerized tomography (SPECT, General Electric^®^) with ^99m^Tc-D,L-Hexamethylene-propyleneamine oxime (^99m^Tc-HmPAO) and video-electroencephalography (v-EEG; Easy II Cadwell^®^) using 19 scalp electrodes and foramen ovale electrodes ([@b19]) removing AED from the second to day of recording.

This research was approved by the Ethical Committee of the Hospital la Princesa and informed consent was obtained from the parents because the patient was under 18 years.

SPECT imaging studies were performed using 740 MBq of ^99m^Tc-HmPAO, with a low-energy high-resolution collimator, simple-head camera (Starcam 3200, General Electric^®^) and 96 projections of 22 s each using a 64 × 64 matrix. Slices were reconstructed by filtered back projection using a Butterworth filter (order 10 with a 0.6 cut-off).

V-EEG recording was performed with a bandwidth of 1--70 Hz for scalp electrodes and 1--100 Hz for FOE recording, with a sampling rate of 200 Hz.

Etomidate (Janssen-Cilag^®^) was intravenously applied in the resting condition, with the patient resting in bed, face up, under continuous supervision of an expert anesthesiologist at a dose of 0.1 mg/kg. Perfusion was performed in approximately 1 min. Electrocardiogram and capillary oxygen saturation (pulsioximetry) were continuously monitored throughout the process. Immediately after the etomidate infusion, a bolus of ^99m^Tc-HmPAO was intravenously injected. Brain SPECT was acquired in the 30 min after the complete recovery of the patient.

Kinetic model
-------------

To analyze the theoretical kinetic behavior of ^99m^Tc-HmPAO, we used a numerical model including four compartments (see [Figure 2B](#fig2){ref-type="fig"}) and four parameters ([@b1]). It is important to keep in mind that the kinetic parameters are taken from biological data, but not adjusted for our patient. The basic assumption was that ^99m^Tc-HMPAO behaves according to the microsphere model and exhibits high rate extraction (76%) by the brain tissue during the first microcirculatory pass ([@b16]). Numerical solutions of the model were obtained by developing a home-made program using the Runge-Kutta method for solving differential equations, implemented in MATLAB R2007a (MathWorks, Natic, USA) and running on a personal computer (Pentium IV, 1 Gb RAM).

![SPECT results and mathematical model of blood-brain ^99m^Tc-HmPAO distribution. **A**) Basal (left) and etomidate-activated (right) SPECT recordings. The arrow shows the hyperperfusion on the right temporo-occipital area (around fusiform and lingual gyri) that corresponds to the most occipital FO electrodes. **B**) Kinetic model for numerical solution of distribution for lipophilic and hydrophilic ^99m^Tc-HmPAO in blood and brain, according to a four-compartment model. The first-order rate constants are (min^−1^) *k~1~* = 0.81; *k~2~* = 0.35; *k~3~* = 0.92 and *k~4~* = 0.25 -[@b1]; **C**) Kinetic evolution of the model during the first 3.5 min after ^99m^Tc-HmPAO iv perfusion that shows the distribution in the different compartments; the broken-blue line represents the evolution of intracellular hydrophilic radio-tracer. The first arrow (from left) marks the start of seizure and the second one indicates the end.](ndt0401-305-02){#fig2}

Results
=======

The scalp EEG showed the presence of frequent right temporal sharp waves, usually grouped in patterns, intermingled with irregular slow waves. MRI was normal and interictal SPECT showed inconclusive results, with left temporal antero-mesial hypoperfusion doubtful.

Etomidate was intravenously applied by an anesthesiologist (MLM) whereas the patient stayed in the v-EEG monitoring unit. Ten seconds later, ^99m^Tc-HmPAO was iv perfused (LD-G) in order to obtain a pharmacologically activated SPECT. Fifty two seconds after ^99m^Tc-HmPAO injection, a seizure begun with head version to left, followed by left arm hypertony, oral automatisms and mild disconnection. Fifty-two seconds thereafter, the seizure finished and the patient recovered consciousness. No stupor or paralysis was observed, but a mild disorientation and agitation persisted for 25 seconds.

v-EEG recording showed a beta/gamma low voltage pattern in the right posterior mesial area (right FO electrodes \#1 to \#3), as we can observe in [Figure 1](#fig1){ref-type="fig"}. A focal desynchronization was observed in the right temporo-occipital area of the scalp.

![Recording of v-EEG during administration of etomidate and the subsequent seizure observed. Discontinuous arrow marks the end of etomidate infusion. Continuous arrow shows the ^99m^Tc-HmPAO infusion. Arrowhead indicates the start of seizure and double arrowhead marks the end of it.](ndt0401-305-01){#fig1}

Injection of the radiotracer began immediately after etomidate and 52 sec. before a seizure started. A localized region of intense hyperperfusion was observed only in the right posterior mesial temporal lobe ([Figure 2A](#fig2){ref-type="fig"}, arrow). This region fits well with right FOE 1--3, which were involved in the origin of the seizure. No changes were observed in other regions compared with interictal SPECT performed after a 24-h seizure-free period.

The numeric simulation of the model (see [Figure 2C](#fig2){ref-type="fig"}) showed that, in theory, at least, the hydrophilic brain concentration at the beginning of the seizure was approximately 18.9% of the total radiotracer injected, with only 36.6% remaining lipophilic in the blood. At the conclusion of the seizure, the theoretical brain hydrophilic concentration was 42.3% and only 15.3% of the radio-tracer persisted in its lipophilic form in the blood. This implies that practically all the available ^99m^Tc-HmPAO had been extracted by the end of seizure. Of course, we are conscious that these results only show the compatibility between the theoretical model and the time course of events observed in our patient.

Discussion
==========

This paper is the first report of an instance where the authors have knowledge of a true-early ictal SPECT, with the radiotracer injection performed at an adequate instant, demonstrated by means of bioelectrical recording.

An intense increase in regional cerebral blood flow is one of the hallmarks of partial-onset seizures. This is probably due to an increase in regional synaptic activity and changes in neurotransmission. Usually, the ^99m^Tc-HMPAO infusion is performed briefly after the seizure starts and, moreover, a delay must be overcome before the radiotracer gets to the brain. So, ictal SPECT, although it is the most sensitive and reliable neuroimaging procedure for delineating the epileptogenic area in patients with medically intractable epilepsy ([@b3]), probably shows an increase in regional cerebral perfusion that is surely related to the seizure ([@b26]), but is almost certainly indicating propagation from the area of ictal onset.

What is more important, if the delay between seizure onset and injection is big enough, a false lateralization or localization on ictal SPECT due to the "postictal switch" phenomenon can be observed ([@b18]). Thus, the early injection of radiotracer has been considered the most important factor for seizure localization.

Taking into account that a majority of the radiotracer will be taken up in the first pass and that it takes around 30 seconds for the tracer to reach the brain, we can reasonably assume that a small amount of the ligand (\<19%) probably would be absorbed previous to the seizure onset (pre-ictal state). However, as we can observe from [Figure 2C](#fig2){ref-type="fig"}, the most important amount of radiotracer will be taken up by the brain during the seizure (period between both arrows).

The safest and most reproducible way to control the moment of injection could be through the use of a pharmacological activation of the seizures. However, this possibility is far from being ready to use ([@b7]; [@b14]). In the model that we are developing in order to overcome that problem, the infusion of etomidate induces important changes in the cerebral regional perfusion, but usually with no associated seizures ([@b8]). Indeed, this case was the only one presenting a crisis out of 46 patients.

In summary, we are conscious that the case reported here was a lucky occurrence, in which the correct order of events allowed to us to demonstrate that an increase in regional cerebral perfusion would be produced in the cerebral area that started the seizure. The systematic methodology in pharmacological activated SPECT with etomidate could produce reproducible and consistent results even without pharmacologically activated seizures. However, more studies are needed before this point will be definitely established.
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